Rethinking Clinical Trials

SEPTEMBER 28, 2023

It will be a stepped-wedge randomized trial at 12 Nationwide Primary Care Clinics with adaptations and implementation and parent, staff, and provider engagement. Discussion Themes -What did stakeholder engagement change in the process? Learn more Read more about PARENT in JAMA.

Trials 269

Trials Clinical Trials Clinical Trials Research 269

Rethinking Clinical Trials

FEBRUARY 22, 2023

The engagement with the original Apple health study was not good, about 30-40%. In Heartline, the older population engaged much more than I thought they would, 90% engagement initially and fell after a few months to 80-85%. We asked why are you participating and engaging with the app?

Clinical Trials 130

Clinical Trials Clinical Trials Trials Nurses 130

Rethinking Clinical Trials

FEBRUARY 14, 2024

Centers did not engage in the same way or even the same way as their nearest neighbor. When people understood what we were trying to do, embed research into clinical care, people really engaged and a few regional directors made participation one of the drivers of research in their region and helped us get initial groundwork.

Clinical Trials 152

Clinical Trials Clinical Trials Cardiology Trials 152

Rethinking Clinical Trials

NOVEMBER 1, 2022

– The creative multi-faceted approach to recruitment that includes diverse stakeholder engagement could be successful in creating research registries for other important health issues. pctGR, @Collaboratory1.

Trials 130

Trials Clinical Research Vaccination Vaccine 130

Rethinking Clinical Trials

MARCH 28, 2023

project has very robust approaches to engaging patients across the continuum of the research from the identification of research questions to the planning phase to the implementation phase to the analysis phase and out to the dissemination of results. Data are drawn from millions of EHRs with growing links to patient-reported and payor data.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Rethinking Clinical Trials

OCTOBER 26, 2023

PCORnet is engaging with sites to support the ITAP clinical study for de novo clearance of a qualitative POC HCV test-to-treat platform. Tags #pctGR, @Collaboratory1 The post Grand Rounds October 20, 2023: A National Initiative to Eliminate Hepatitis C in the United States – Why This Matters to Clinical Trialists (Rachael L.

Clinical Research 141

Clinical Research Clinical Trials Clinical Trials Research 141

Rethinking Clinical Trials

AUGUST 3, 2023

When we are communicating about our science, it is important to engage with traditional media and take the time to get to know reporters who are interested in the science. Engaging with social media is important, particularly as false information starts to spread, it can make its way into traditional media.

Medicine 130

Medicine Research Vaccination Vaccine 130

Pharmaceutical Technology

FEBRUARY 10, 2023

This is not the first treatment to come with a high price tag. On November 22, 2022, the FDA approved CSL Behring’s Hemgenix (etranacogene dezaparvovec), the first gene therapy treatment for hemophilia B, with a staggering manufacturer price of $3.5

Gene Therapy 263

Gene Therapy Marketing Gene Drugs 263

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Engagement channels. Virtual connections.

Regulation 97

Regulation Marketing Sales Branding 97

Rethinking Clinical Trials

MARCH 6, 2024

The study did find substantial effects on diet and healthcare engagement. Tags #pctGR, @Collaboratory1 The post Grand Rounds March 1, 2024: Effect of an Intensive Food-As-Medicine Program on Health and Health Care Use: Evidence from a Randomized Clinical Trial (Joseph Doyle, PhD) appeared first on Rethinking Clinical Trials.

Clinical Trials 141

Clinical Trials Clinical Trials Medicine Trials 141

pharmaphorum

JULY 23, 2019

But, as they push the envelope, what are the implications for pharma’s work in customer engagement? The expert panel will consider exclusive research carried out by Tag and pharmaphorum across the US, Europe and Asia-Pacific among senior decision-makers in pharma and FMCG marketing.

Marketing 52

Marketing Production Development Research 52

World of DTC Marketing

SEPTEMBER 7, 2022

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. DTC commercials will be replaced by unbranded ads that look to engage patients and caregivers by forming a relationship based on making them more intelligent about their treatments.

Pharma Companies 210

Pharma Companies Marketing Drugs Production 210

Rethinking Clinical Trials

DECEMBER 6, 2022

This trial turned out to be more challenging than anticipated. It was a labor of love; the site payment was low; we asked friends to be sites in the trial. Sites have a lot of trials that are competing. One pays more than another. We did what we could to make the entry criteria as easy as possible. pctGR, @Collaboratory1.

Trials 130

Trials Clinical Trials Clinical Trials Compliance 130

Rethinking Clinical Trials

NOVEMBER 9, 2022

We engaged fellows by making them part of the research team, ensured mentorship, networking, etc. What we tried to emphasis was engaging cardiovascular fellows in year 2 or 3 when there are less clinical responsibilities and more elective time. Learn more. Visit the CardioNerds website. Discussion Themes. pctGR, @Collaboratory1.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Rethinking Clinical Trials

AUGUST 18, 2022

Researchers push the focus on the population, but do we have the level of cultural humility required, and are we trustworthy enough to be doing this type of research and engaging these populations? There are barriers at the health care professional and researcher level. What does pragmatic mean to minoritized racial and ethnic groups?

Clinical Trials 130

Clinical Trials Clinical Trials Trials Insulin 130

Pharmaceutical Technology

MAY 2, 2023

Marketed bispecific antibodies are largely bispecific T-cell engagers (BiTEs), which work by directing T-cells to antigen-expressing tumour cells. IO therapies come with a hefty price tag, with ICI therapies in the US typically exceeding $100,000, while cell therapies can exceed $400,000. Cost-related unmet needs also scored highly.

Genetic Engineering 130

Genetic Engineering Antibody Clinical Trials Clinical Trials 130

Rethinking Clinical Trials

FEBRUARY 28, 2024

But there are concerns to developing DCTs including lack of standardization and validation, regulatory and ethical uncertainties, engagement vs. coercion, data security and privacy issues, technological literacy and access, resistance to change and adoption, and lack of “safe” sharing. from 2021 to 2026.

Clinical Trials 141

Clinical Trials Clinical Trials Trials Clinical Research 141

Rethinking Clinical Trials

AUGUST 30, 2023

The hypothesis was that the RA PRO dashboard used during clinical encounters will increase patient engagement, foster shared decision making, and improve health outcomes for patients with RA. The RA PRO dashboard was tested as part of a stepped wedge, cluster randomized trial at the clinician level.

Trials 141

Trials Clinical Research Coordinator Medicine Clinical Trials 141

Rethinking Clinical Trials

NOVEMBER 21, 2023

The idea was to engage the patient, providers, and healthcare system leaders to design, refine, and implement the pilot. The second aim was to conduct a pilot intervention to demonstrate feasibility of delivering the intervention and preliminary effects in a 3 healthcare systems. The study would then recalculate the gaps.

Clinical Trials 141

Clinical Trials Clinical Trials Trials Development 141

Rethinking Clinical Trials

MARCH 1, 2023

We have found that having an involved investigator in each network improves engagement. Discussion Themes – What does a study champion mean in the context of this study? One network is the lead, but the trial will be available in all four U.S. We are working on inclusion and making sure all of our trials have buy in across the group.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Packaging 130

Rethinking Clinical Trials

AUGUST 28, 2023

From a clinical perspective, the team learned the importance of keeping providers up to date on the study progress in an efficient and streamlined way and experienced unforeseen difficulties with engaging with community PSPs. – Are you looking to engage with patients who have had imaging, and how does that impact the care path?

Trials 130

Trials Research Medicine Doctors 130

Rethinking Clinical Trials

MARCH 21, 2023

Patient self-reporting improves symptom monitoring and outcomes in routine cancer care and clinical research by expanding our understanding of the patient experience and engaging patients. From a health services research perspective, it demonstrates how hard it is to change a simple process, even if it makes a lot of intuitive sense.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Rethinking Clinical Trials

JULY 19, 2023

How do you elevate the pharmacists to get embedded in the clinics and remain engaged? Tags #pctGR, @Collaboratory1 The post Grand Rounds July 14, 2023: Lessons From the COORDINATE-Diabetes Trial (Christopher B. How do you incentivize patients to see this through? Granger, MD; Neha J.

Trials 130

Trials Cardiology Medicine Nurses 130

Rethinking Clinical Trials

FEBRUARY 9, 2023

The team also engaged with a diverse array of providers from multiple hospitals and specialties. With every iteration of testing, the team worked to identify barriers in provider workflow. The number of testing rounds, as well as the quality of usability testing, was critical in understanding workflows and the best moment to launch the tool.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Pharmaceutical Technology

APRIL 5, 2023

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. BL: The ISCT engages with professionals in 65 countries. We engage] with not only other professional societies and professionals, but also people in government. At the end of last year, we had 2,800.

Gene Therapy 147

Gene Therapy Gene Engineer Production 147

Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Antibody 130

Antibody DNA Development Vaccination 130

pharmaphorum

APRIL 5, 2022

The therapy is a bispecific T cell engager (BiTE) molecule, consisting of a soluble TCR targeting gp100 expressed on cancer cells fused to a protein that binds CD3 receptors on lymphocytes. It’s the first treatment for mUM in the EU, as well as the first BiTE drug to treat a solid tumour.

Protein 52

Protein Sales Drugs Trials 52

XTalks

MAY 2, 2024

Training and Retention PJ Andress, Senior Account Manager at Intertek Alchemy , shared insights on the role of engaging and effective training programs in employee retention within the food industry. “Efficiency is the biggest challenge today and technologies like IoT are addressing this by reducing the need for manual checks.”

Compliance 110

Compliance Regulation Production Containment 110

XTalks

JANUARY 28, 2022

Kimmtrak has also become the first bispecific T cell engager to be FDA-approved for the treatment of a solid tumor. Kimmtrak has a price tag of $18,760 per vial, which amounts to a weekly dose. Kimmtrak is part of a novel class of bispecific T cell immunotherapies being developed by Immunocore.

FDA Approval 98

FDA Approval Development Licensing Licensing 98

pharmaphorum

SEPTEMBER 15, 2020

This gives them huge amounts of customer data that allows them to shape and personalise the way they engage with their customers, not least thanks to the direct-to-consumer sales model they often offer. Jeremy Richter, Tag. Build on the rapid responses to COVID-19.

Branding 128

Branding Marketing Pharma Companies Life Science 128

pharmaphorum

JANUARY 31, 2023

Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of. Patient engagement solutions can also help reduce the discrepancy between the efficacy of medications in clinical trials and their effectiveness in real-world use. Where are we going?

Clinical Trials 52

Clinical Trials Clinical Trials Trials Vaccination 52

Rethinking Clinical Trials

AUGUST 28, 2023

The working group is engaging with academic stakeholders to determine new approaches to enhance transparency. Tags #pctGR, @Collaboratory1 The post Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Rethinking Clinical Trials

AUGUST 28, 2023

The working group is engaging with academic stakeholders to determine new approaches to enhance transparency. Tags #pctGR, @Collaboratory1 The post Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Rethinking Clinical Trials

SEPTEMBER 22, 2022

What was the type of engagement; were people aware clinicians were involved? Another trial is called NUDGE-DM using the same system for identifying patients with diabetes to test communication strategies for optimizing the use of guideline directed medical therapy for T2D patients with established CVD. Discussion Themes. -I Learn more.

Trials 130

Trials Cardiology Vaccination Vaccine 130

pharmaphorum

SEPTEMBER 29, 2021

Despite soaring social media engagement, email still is the number one communications channel of most corporations large and small. And what’s true for the use of email usually applies to other forms of electronic and social engagement, too. Never engage in conversations when angry or emotional. • Reduce your readership.

Life Science 118

Life Science Containment Sales Marketing 118

pharmaphorum

DECEMBER 17, 2021

Aduhelm (aducanumab) was approved by the FDA in June, but has been held back by a glacial rollout as clinicians have questioned the data on which the decision to clear the drug was based, plus a $56,000 per year price tag, which has in turn led to pushback by payers.

Trials 52

Trials Sales Marketing FDA Approval 52

Drug Discovery World

MAY 22, 2023

But are these price tags a barrier to access? He is engaged in the increase of effective scientific communication for a variety of stakeholders and populations to advance the development of and access to cell and gene therapies. million per dose.

Gene Therapy 52

Gene Therapy Gene Drugs Contamination 52